A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NAT / noradrenaline transporter

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NAT  (>> Co-occurring Abbreviation)
Long Form:   noradrenaline transporter
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Involvement of catecholaminergic and GABAAergic mediations in the anxiety-related behavior in long-term powdered diet-fed mice. ADHD, DAT, EPM, SI
2018 Effect of Deep Brain Stimulation of the ventromedial prefrontal cortex on the noradrenergic system in rats. CRF, DBS, ERK, LC, SCC, TH
2017 Oxytocin in corticosterone-induced chronic stress model: Focus on adrenal gland function. VMAT2
2016 REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular. MAO, NA, NREMS, REMS, TH
2015 Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle. ADHD, DNAB, ITI, NRI
2015 Living without DAT: Loss and compensation of the dopamine transporter gene in sauropsids (birds and reptiles). DA, DAT
2015 mu-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons. ---
2014 Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effects. ---
2013 Gamma irradiation and targeted radionuclides enhance the expression of the noradrenaline transporter transgene controlled by the radio-inducible p21(WAF1/CIP1) promoter. MIBG
10  2013 Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species. 131I-MIBG, ROS
11  2013 The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells. ---
12  2012 Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks. ITI
13  2012 In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy. MIBG
14  2012 Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter. ADP
15  2012 Iodine-123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography. SPECT
16  2012 LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. LV, MIBG, NA, PET, RCSD
17  2012 The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine. DAT
18  2011 Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. ADs, DAT, KO, MATs, MDD, NA, SERT
19  2011 Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas. DA, GEP-NETs, GUS, PCC, PGL, sst, VMAT
20  2011 I-NKJ64: a novel single photon emission computed tomography radiotracer for imaging the noradrenaline transporter in brain. SPECT
21  2010 Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity. ---
22  2009 Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter. ---
23  2009 Interference of the noradrenergic neurotoxin DSP4 with neuronal and nonneuronal monoamine transporters. hNAT, OCTs
24  2008 Effects of South African traditional medicine in animal models for depression. AC, BD, DAT, MW, SERT, TST, XU
25  2008 New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter. ---
26  2008 Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors. NE, sst
27  2008 Radiation quality-dependent bystander effects elicited by targeted radionuclides. LET
28  2007 A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo. TMX
29  2007 Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. BDNF, MHPG
30  2006 Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. MIBG
31  2005 Application of targeted radiotherapy/gene therapy to bladder cancer cell lines. ---
32  2005 Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy. ---
33  2005 Comparative studies of PC12 and mouse pheochromocytoma-derived rodent cell lines as models for the study of neuroendocrine systems. MPC, mRNA, NSE, PNMT, TH
34  2005 Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma. c.a, MABG, MIBG, NCA
35  2005 Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells. DMI, NA
36  2005 Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma. CgA, HPLC, PNMT, TH
37  2004 An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects. TMS
38  2004 Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate. ---
39  2003 Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors. MIBG
40  2003 Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. 5-HTP, DAT, DRN, h5-HTT, USV
41  2002 Catecholamine-related gene expression correlates with blood pressures in SHR. alpha1A-R, alpha2A-R, PNMT, SD, SHR, WKY
42  2002 Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy. GFP, TMM, TMS
43  2002 Up-regulation of noradrenaline transporter in response to prolonged exposure to ketamine. ---
44  2002 Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure. beta-AR, GRK, LV, MCT, RV
45  2001 A gene therapy/targeted radiotherapy strategy for radiation cell kill by. MIBG
46  2001 Differential expression of the noradrenaline transporter in adrenergic chromaffin cells, ganglion cells and nerve fibres of the rat adrenal medulla. AADC, DBH, GAP-43, PNMT, RT-PCR, TH
47  2001 Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. cAMP, cGMP
48  2001 Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill. hTR
49  2000 6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporter. 6F-DA, ROS
50  2000 A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma. ---
51  2000 Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. DAT, HACU, SERT
52  2000 No-carrier-added 123I-MIBG: an initial clinical study in patients with phaeochromocytoma. MIBG, NCA
53  1999 Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells. ---
54  1999 Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine. ---
55  1999 Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. DAT
56  1998 Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. bNAT, NA